APLS · Categories · Form 3

APLS - SEC Form 3 initial insider statements

Apellis Pharmaceuticals Inc. (APLS) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for APLS

• 62d
  SEC Form 3 filed by new insider Biogen Inc.

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 96d
  SEC Form 3 filed by new insider Dolsten Mikael

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 278d
  SEC Form 3 filed by new insider Meltzer Leslie

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 374d
  SEC Form 3 filed by new insider Boucher Kelley

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 412d
  SEC Form 3 filed by new insider Wheeler Craig A

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 513d
  SEC Form 3 filed by new insider Walbert Keli

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 1245d
  SEC Form 3: New insider Baumal Caroline claimed ownership of 133 shares

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 1249d
  SEC Form 3: New insider Baumal Caroline claimed ownership of 133 shares

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 1740d
  SEC Form 3 filed by new insider Chopas James George

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)
• 1885d
  SEC Form 3: Jeffrey Mark Delong claimed ownership of 8,698 units of Common Stock

  3 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)

Other APLS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends